ATE135232T1 - Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen - Google Patents

Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen

Info

Publication number
ATE135232T1
ATE135232T1 AT92901009T AT92901009T ATE135232T1 AT E135232 T1 ATE135232 T1 AT E135232T1 AT 92901009 T AT92901009 T AT 92901009T AT 92901009 T AT92901009 T AT 92901009T AT E135232 T1 ATE135232 T1 AT E135232T1
Authority
AT
Austria
Prior art keywords
treating
pharmaceutical compositions
cell degeneration
cell malignancies
cell
Prior art date
Application number
AT92901009T
Other languages
English (en)
Inventor
Jacques Banchereau
France Thierry De
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Application granted granted Critical
Publication of ATE135232T1 publication Critical patent/ATE135232T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT92901009T 1990-12-13 1991-12-10 Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen ATE135232T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90403585A EP0490006B1 (de) 1990-12-13 1990-12-13 Pharmazeutische Zusammensetzungen zur Behandlung von bösartigen B-Zellenkrankheiten

Publications (1)

Publication Number Publication Date
ATE135232T1 true ATE135232T1 (de) 1996-03-15

Family

ID=8205785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92901009T ATE135232T1 (de) 1990-12-13 1991-12-10 Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen

Country Status (16)

Country Link
EP (2) EP0490006B1 (de)
JP (1) JPH06504767A (de)
AT (1) ATE135232T1 (de)
AU (1) AU9072191A (de)
CA (1) CA2098509A1 (de)
CZ (1) CZ113593A3 (de)
DE (1) DE69117974T2 (de)
DK (1) DK0561927T3 (de)
ES (1) ES2084995T3 (de)
FI (1) FI932650L (de)
GR (1) GR3019699T3 (de)
HU (1) HU210009B (de)
IE (1) IE64157B1 (de)
OA (1) OA09788A (de)
SK (1) SK59193A3 (de)
WO (1) WO1992010201A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2142862C (en) * 1992-08-19 2000-05-30 Jerome Schwartz Method for inhibiting hiv replication using il-4
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004044A1 (en) * 1990-09-06 1992-03-19 Schering Corporation Use of il-4 to treat solid tumors

Also Published As

Publication number Publication date
SK59193A3 (en) 1994-01-12
FI932650A0 (fi) 1993-06-10
HU210009B (en) 1995-01-30
DE69117974T2 (de) 1996-07-25
IE914328A1 (en) 1992-06-17
DK0561927T3 (da) 1996-07-29
CZ113593A3 (en) 1994-01-19
EP0561927A1 (de) 1993-09-29
GR3019699T3 (en) 1996-07-31
HUT64478A (en) 1994-01-28
IE64157B1 (en) 1995-07-12
EP0561927B1 (de) 1996-03-13
FI932650A7 (fi) 1993-06-10
JPH06504767A (ja) 1994-06-02
EP0490006B1 (de) 1994-06-22
OA09788A (en) 1994-04-15
ES2084995T3 (es) 1996-05-16
CA2098509A1 (en) 1992-06-14
WO1992010201A1 (en) 1992-06-25
FI932650L (fi) 1993-06-10
EP0490006A1 (de) 1992-06-17
HU9301719D0 (en) 1993-09-28
AU9072191A (en) 1992-07-08
DE69117974D1 (de) 1996-04-18

Similar Documents

Publication Publication Date Title
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
JO1552B1 (en) New pyridizinamine derivatives
SE8503680L (sv) Indolderivat
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69100364D1 (de) Verwendung von N-Myristoyl-(S)-Phenylalanin zur Herstellung eines Medikaments zur Behandlung von Krankheiten mittels Hemmung der Myristoylierung.
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
GR3022321T3 (en) Use of il-4 to treat solid tumors
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
MD940152A (ro) Compoziţie farmaceutică pentru tratarea infecţiilor şi bolilor, provocate de virusul hepatitei V (HBV)
DE69232417D1 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
DE69117974D1 (de) Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen
FI810380L (fi) Fenylpiperazinderivat av 1,3,4-oxadiazolylfenoler deras framstaellning och dessa innehaollande terapeutiska aemnen
DK0420798T3 (da) Antimikrobielle præparater
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
SE8106190L (sv) Addukter av 1,8-dihydroxi-9-antron, forfarande for framstellning derav och anvendning derav inom human- eller veterinermedicinen samt inom kosmetiken
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee